Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice

The maintenance of healthy adipose tissues is essential for efficient regulation of energy homeostasis. Nuclear factor-erythroid 2-related factor 1 (NFE2L1, also known as Nrf1), a CNC-bZIP protein, is a master regulator of the cellular adaptive response to stresses. To investigate the role of NFE2L1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2018-09, Vol.503 (1), p.264-270
Hauptverfasser: Hou, Yongyong, Liu, Zhiyuan, Zuo, Zhuo, Gao, Tianchang, Fu, Jingqi, Wang, Huihui, Xu, Yuanyuan, Liu, Dianxin, Yamamoto, Masayuki, Zhu, Beibei, Zhang, Yiguo, Andersen, Melvin E., Zhang, Qiang, Pi, Jingbo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The maintenance of healthy adipose tissues is essential for efficient regulation of energy homeostasis. Nuclear factor-erythroid 2-related factor 1 (NFE2L1, also known as Nrf1), a CNC-bZIP protein, is a master regulator of the cellular adaptive response to stresses. To investigate the role of NFE2L1 in adipocytes, we bred a line of mice with adipocyte-specific Nfe2l1 knockout (Nfe2l1(f)-KO), and found that Nfe2l1(f)-KO mice exhibited a dramatically reduced subcutaneous adipose tissue (SAT) mass, insulin resistance, adipocyte hypertrophy, and severe adipose inflammation. Mechanistic studies revealed that Nfe2l1 deficiency may disturb the expression of lipolytic genes in adipocytes, leading to adipocyte hypertrophy followed by inflammation, pyroptosis, and insulin resistance. Our findings reveal a novel role for NFE2L1 in regulating adipose tissue plasticity and energy homeostasis. •Nfe2l1(f)-KO mice exhibit diminished subcutaneous adipose tissues.•Nfe2l1(f)-KO mice show severe adipocyte hypertrophy and adipose inflammation.•Nfe2l1(f)-KO mice develop glucose intolerance and insulin resistance.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2018.06.013